全膝关节置换术中骨内局部预防性抗生素应用
预防性抗生素可降低全膝关节置换术后假体周围关节感染风险,其效果取决于抗生素选择与给药时机。头孢菌素为常用药物,但耐药菌增多导致万古霉素追加使用,而全身给药存在时机与不良反应问题。止血带远端骨内局部给药是一种替代方式,文献报告其组织浓度高于静脉给药,可提供等同或增强的预防效果并减少不良反应。本文描述该技术并总结相关临床文献。
要点
- 预防性抗生素降低全膝关节置换术后假体周围关节感染风险,效果取决于药物选择与给药时机。
- 头孢菌素为常用预防药物,耐药菌增多致万古霉素追加使用,但全身给药存在时机与不良反应问题。
- 止血带远端骨内局部给药可使组织抗生素浓度高于静脉给药,提供等同或增强的预防效果并减少不良反应。
核心结论
- 止血带远端骨内局部给予预防性抗生素是一种有吸引力的替代给药方式,文献报告其组织浓度高于静脉给药,可提供等同或增强的预防效果并减少不良反应。
研究设计与样本
- 本文为述评(annotation),描述骨内给予抗生素的技术并总结截至目前的 relevant 临床文献。
主要发现
- 许多作者报告骨内预防性给药相比静脉给药可获得更高的组织抗生素浓度,提供等同或增强的预防效果并减少不良反应。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prophylactic antibiotics are important in reducing the risk of periprosthetic joint infection (PJI) following total knee arthroplasty. Their effectiveness depends on the choice of antibiotic and the optimum timing of their administration, to ensure adequate tissue concentrations. Cephalosporins are typically used, but an increasing number of resistant organisms are causing PJI, leading to the additional use of vancomycin. There are difficulties, however, with the systemic administration of vancomycin including its optimal timing, due to the need for prolonged administration, and potential adverse reactions. Intraosseous regional administration distal to a tourniquet is an alternative and attractive mode of delivery due to the ease of obtaining intraosseous access. Many authors have reported the effectiveness of intraosseous prophylaxis in achieving higher concentrations of antibiotic in the tissues compared with intravenous administration, providing equal or enhanced prophylaxis while minimizing adverse effects. This annotation describes the technique of intraosseous administration of antibiotics and summarizes the relevant clinical literature to date.
引用
- Young SW, Chen W, Clarke HD, et al. Intraosseous regional prophylaxis in total knee arthroplasty. Bone Joint J. 2023. PMID: 37907081. doi:10.1302/0301-620X.105B11.BJJ-2023-0708
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。